Trump picks Dr. Oz to run massive Medicare, Medicaid agencies
By 
Adrianne Appel2024-11-22T14:17:00
Dr. Mehmet Oz, President-elect Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services (CMS), has a mandate from Trump to “take on the illness industrial complex” and to cut costs.
Oz, a heart surgeon and former director of the Cardiovascular Institute at Columbia Presbyterian Medical Center, is best known for his long-running television series “The Dr. Oz Show.”
He was controversial in medical circles for frequently promoting products on his show and making claims about untested and controversial treatments, including for obesity. It was in that role that in 2014 he testified before a Senate subcommittee about deceptive advertising and fraudulent claims in the weight-loss industry. In 2022, he ran for U.S. Senate in Pennsylvania on the Republican ticket and an anti-abortion platform, against Democrat John Fetterman, and lost.
Related articles
-
PremiumTop ethics and compliance failures of 2024
The biggest Compliance Fails of 2024 show the real-world consequences of noncompliance for the companies that faltered, but also for their customers and their employees.
-
News BriefSEC Chair Gary Gensler to step down Jan. 20 after busy, controversial tenure
Securities and Exchange Commission Chair Gary Gensler will step down from his position as the top U.S. regulator of Wall Street when Donald Trump is sworn in as president on Jan. 20, ending weeks of speculation about his future.
-
PremiumPresident-elect Trump’s Commerce Department pick Howard Lutnick to head tariff, trade agenda
President-elect Donald Trump announced he plans to appoint Cantor Fitzgerald President and CEO Howard Lutnick to lead the U.S. Commerce Department, as the incoming administration is expected to charge import tariffs against friends and foes.
More from Regulatory Policy
-
ArticleNavigating HHS and FDA’s overhaul of the food and beverage industry
Under the Trump administration, the Department of Health and Human Services and the Food and Drug Administration have been hellbent on eliminating synthetic food dyes from food and beverage products, forcing a jarring and costly overhaul with cascading impacts on the operations of the entire industry.
-
PremiumU.K. FCA establishes framework for unlisted companies to trade shares on a ‘buyer-beware’ basis
Private companies that are keen to trade their shares but do not wish to become listed have gained another way to trade their shares. The U.K. government completed its initial review and published rules for the system in June.
-
ArticleDOJ is ramping up, not ramping down, health care fraud enforcement
While the Trump administration may have shifted away from pursuing small, white-collar, financial crimes, its focus on health care fraud cases is as hot as ever.